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Abstract:  
 In this retrospective review, the use of extracorporeal cardiopulmonary resuscitation 
(ECPR) using extracorporeal membrane oxygenation (ECMO) was assessed in the management 
of refractory ventricular fibrillation (VF) and ventricular tachycardia (VT) out-of-hospital 
cardiac arrest (OHCA). Multiple factors were evaluated such as the duration of manual or 
mechanical cardiopulmonary resuscitation (CPR), ECPR protocols and the rate of favorable 
neurologic outcomes for these OHCA patients. Survival with a favorable neurologic outcome is 
defined as cerebral performance categories (CPC) 1 or 2. Although CPR remains and will 
continue to be a critical component in the management of cardiac arrest, the persistently high 
mortality rate of the condition warrants further intervention. Established ECPR protocols include 
timely administration of emergency intervention, patient inclusion and exclusion criteria, 
mechanical CPR, specific cannulation technique, percutaneous coronary intervention (PCI), as 
well as post-catheterization lab management. These protocols have shown encouraging initial 
results with an increased rate of survival with a favorable neurologic outcome when compared to 
management of similar patients with conventional CPR alone. This literature review found that 
there is strong evidence supporting the use of ECPR with ECMO support in the management of 
refractory VF/VT OHCA. Although there exists the need for more randomized control trials, 
implementation of ECMO and ECPR programs have shown to improve neurological outcomes 
for these patients. 
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Introduction: 
Cardiac arrest is one of the deadliest public health problems affecting the world today. 
Approximately 400,000 people in the United States suffer out-of-hospital cardiac arrest (OHCA) 
each year.1 Cardiac arrest is most commonly caused by cardiac disease, such as coronary artery 
disease (CAD) and other structural heart diseases.2 Cardiac disease accounts for more deaths 
annually than colorectal cancer, breast cancer, chronic lower respiratory diseases, 
cerebrovascular diseases, diabetes, influenza, pneumonia, auto accidents, HIV and firearms 
combined.3 Patients suffering from OHCA rely heavily on immediate cardiopulmonary 
resuscitation (CPR) efforts to achieve return of spontaneous circulation (ROSC). Despite these 
potential life-saving measures, meager outcomes persist with only 6% of patients surviving to 
hospital discharge.4  
Approximately one-third of patients who suffer OHCA present to emergency medical 
services with a shockable rhythm of either ventricular fibrillation (VF) or pulseless ventricular 
tachycardia (VT).5 These patients will undergo advanced cardiovascular life support (ACLS) 
resuscitative measures with repeated defibrillations and administration of pharmaceutical drugs 
until ROSC is achieved or until patient is pronounced dead. Although VF and VT are considered 
the most treatable rhythms in patients with OHCA, most defibrillation attempts do not result in 
sustained ROSC.6 When patients in VF/VT do not obtain ROSC after three direct current shocks 
and administration of 300mg IV/IO amiodarone, the condition is termed refractory VF/VT.5 The 
dangers of prolonged cardiac arrest increase significantly with each passing minute. Survival 
drops below 5% if ROSC is not achieved within 30 to 45 minutes, as standard CPR provides 
only 10 to 30% of normal blood flow to the heart and 30 to 40% of normal blood flow to the 
brain. 7,8  
 ECPR for OHCA  5 
Extracorporeal CPR (ECPR), using extracorporeal membrane oxygenation (ECMO) for 
hemodynamic support, has recently been shown to enhance survival for patients with refractory 
VF/VT OHCA, with survival rates as high as 40 to 50%.8 With ECMO, patients who are 
unresponsive to conventional resuscitation are provided support as a bridge to recovery, 
destination, or surgery by stabilizing systemic circulation until the underlying cause of the arrest 
is managed.9 The purpose of this literature review is to examine the impact of ECMO and ECPR 
upon the mortality and neurological outcomes in patients with OHCA.  
 
Methods: 
A systematic search was conducted using MEDLINE, PubMed, Google Scholar, and 
UpToDate. Using the Boolean/Phrase mode and the assistance of a research librarian from 
Augsburg University, the search was conducted using the terms ECMO OR extracorporeal 
membrane oxygenation OR ECLS OR extracorporeal life support OR ECPR OR extracorporeal 
cardiopulmonary resuscitation AND OHCA OR out of hospital cardiac arrest AND refractory 
AND CPR. Results were limited to those published in the English language from the year 2010 
to present. The search was limited to the last 10 years to gather only the most recent research. In 
addition, the reference lists of retrieved articles were reviewed to identify additional, potentially 
relevant studies. The search options only included peer reviewed articles that consisted of 
randomized control trials, clinical trials, observational studies, meta analyses, and review 
articles. 
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Background: 
First, a brief introduction to OHCA will be discussed along with the current literature that 
surrounds it, including both CPR and ACLS standard of care. Then a mechanical circulatory 
device called ECMO and its comparison to standard care in the management of OHCA will be 
addressed. Finally, the implications of ECPR will be examined to determine the impact it has on 
the mortality and neurologic outcomes of patients that suffer from OHCA. 
Cardiac arrest is the abrupt cessation of heart function and subsequent circulatory 
collapse, often due to cardiac arrhythmias such as VF or pulseless VT.  Cardiac arrest occurring 
outside of a hospital is one of the leading causes of death in developed countries today. 10 
Without proper cardiac function, the heart fails to profuse blood and oxygen to vital organs, most 
importantly the brain, leading to hypoxic-ischemic brain injury. The aim of the care for patients 
suffering from cardiac arrest is a neurologically intact survival. Neurologically favorable survival 
outcomes in patients resuscitated worldwide by emergency services is only 5 15%. Critically 
dependent factors of neurologically favorable outcomes are time, resuscitation quality, advanced 
care and the treatment of the underlying cause for the cardiac arrest.11 Neurologically favorable 
outcomes are defined as cerebral performance categories (CPCs) 1 and 2.5 CPC scores are 
categories ranked 1 through 5 that indicate the level of neurologic function after cardiac arrest. 
T        a   a  a  a a  a   a a   a  
functional status and their expected quality of life. CPC scores of 1 or 2 are considered to be 
favorable as they indicate the patient has sufficient cerebral performance and function, and is 
able to carry out daily activities, independently. CPC scores of 3 or greater indicate severe 
cerebral disability with limited cognition and dependence of others for activities of daily living.12 
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When cardiac arrest occurs, the mechanisms of the arrest include ventricular 
tachyarrhythmia, asystole, or pulseless electrical activity of the heart. Furthermore, ventricular 
tachy-arrhythmias resulting in cardiac arrest include VF and VT. For cardiac arrest patients, the 
most frequent cause of death is VT (83%). The most prominent mechanism is VF resulting from 
untreated VT (62%).10 As previously stated, VF/VT is a favorable prognostic marker for patients 
with cardiac arrest, as they are both shockable rhythms. Still, 50% of patients in VF/VT OHCA 
are refractory to treatment, as they fail to achieve sustained ROSC after 3 defibrillation attempts 
and administration of 300 mg amiodarone. The likelihood of survival with neurologically 
favorable outcomes for patients with refractory VF/VT declines with longer duration of standard 
CPR, dropping below 5% if ROSC is not achieved within 30 to 45 minutes of standard ACLS.8 
These poor statistics for survival suggest the need for a modified approach to OHCA that is 
refractory to conventional treatment. 
There are critical steps that must be taken to increase chances of survival for patients 
with OHCA. These steps include fast recognition of cardiac arrest, activation of Emergency 
Medical Services (EMS), early CPR, rapid defibrillation, effective advanced life support and 
integrated care after cardiac arrest.13 Though the list of critical steps can seem extensive in a 
rather emergent situation, the integration of all these components in a short period of time is 
essential to the survival with a favorable neurologic outcome in these patients. Missing one of 
these critical steps can be detrimental to this desired outcome. When an individual goes into 
cardiac arrest, timely bystander recognition of the situation can serve as the most vital to all of 
these steps because without it, many of the subsequent steps may not take place. First, fast 
recognition will give the best chance for immediate bystander CPR response, which is critical to 
improve rates of effective resuscitation and defibrillation, thereby, increasing the likelihood of 
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survival and a favorable neurologic outcome. Fast recognition will also help bystanders to 
immediately call 911 and mobilize EMS responders to the scene.  
In a study that took place at The Alfred Hospital in Melbourne, Victoria, Australia, a 
protocol was developed for both refractory OHCA and refractory in-hospital cardiac arrest 
(IHCA). This was a prospective observational study called the CHEER trial (mechanical CPR, 
Hypothermia, ECMO and Early Reperfusion). One key component of this study was that a 
shorter time between collapse and arrival to the hospital served as a better prognosis to survival. 
Median time was 48 minutes for survivors compared to 70 minutes for non-survivors.14 This 
emphasizes the need for prompt recognition of cardiac arrest and subsequent EMS activation, 
bystander CPR and transport to the hospital. When bystander CPR is initiated immediately after 
the individual stops breathing, chest compressions can supply blood flow to vital organs until 
ROSC is achieved or other measures are taken. Although VF/VT is a favorable rhythm for 
defibrillation, the standard of care with CPR and ACLS is not always adequate. W  a a  
status is termed a   a  a   ROSC, a a  a   
offers an additional option for survival.  
 
CPR Duration 
 
Multiple studies have shown the amount of time in which a patient receives CPR directly 
correlates to their chance of survival, as each elapsed minute of resuscitation is independently 
associated with lower odds of a favorable neurologic outcome at hospital discharge.8, 15, 16 There 
is no question of the importance of early conventional CPR. Without conventional CPR, cardiac 
arrest patients are unable to perfuse vital organs and ultimately decrease their chance of a 
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favorable functional outcome or survival overall.15 Although CPR is a vital component in the 
survival process of a patient suffering from OHCA, it is not life-sustaining over longer periods of 
time. When CPR is prolonged, it can lead to metabolic derangement, which is associated with a 
reduction in favorable outcomes in terms of overall survival and neurologic favorability8 (CPC 3 
or greater). 
In a study on prolonged resuscitation, Bartos et al. found that the body undergoes 
multiple metabolic changes as the duration of resuscitation increases.8 This study examined 160 
patients from the University of Minnesota ECPR cohort who underwent conventional CPR for 
refractory OHCA prior to initiation of ECMO. Patients who underwent CPR for 40 minutes or 
longer showed an overall decrease in arterial pH, increase in arterial lactic acid and 
paCO2 levels, and an increase in left ventricular wall thickening.8 As previously stated, standard 
CPR provides only 10 to 30% of normal blood flow to the heart and 30 to 40% of normal blood 
flow to the brain.7 The decrease in arterial pH, increase in arterial lactic acid and paCO2 levels, 
and the increase in left ventricular size are most likely caused by incomplete perfusion provided 
by CPR and leads to a collective metabolic imbalance. These additional components can cause 
further complications on top of the original cause of cardiac arrest. For these reasons, prolonged 
efforts are not life-sustaining and therefore new strategies must be incorporated.  
Another component of refractory OCHA is the use of mechanical CPR devices. 
Currently, there are two mechanical CPR devices used in the United States. These include the 
mechanical piston device and the load distributing device. This review will focus on the 
a a    a  T  L  U  Ca a  A  S   LUCAS . T  
LUCAS  is a device that applies mechanical chest compressions, via circulating pistons, at a 
constant rate and depth.6 This device serves a critical role in OHCA management as it allows 
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emergency services to administer other life saving measures all while the patient receives 
consistently adequate chest compression. It also serves EMS by not taking another crew member 
away to administer these compressions. As conventional manual CPR progresses, fatigue sets in 
a    a a . W   LUCAS ,  b  must cycle in and out to 
ensure maximum efficiency and to not compromise the effectiveness of the resuscitation attempt. 
F a , a a  CPR   LUCAS  a       
during transport to hospital. Conventional CPR ceases during transport as it would require EMS 
crew members to be out of their safety harness and put them at risk for injury in the case of an 
automobile accident. 
As mentioned previously, refractory VF/VT OHCA is defined as failure to achieve 
ROSC with ACLS, including 3 attempted defibrillations and administration of 300mg of 
Amiodarone. VF/VT is termed as a shockable rhythm as the electrical shock from the 
defibrillator can restart the heart s rhythm in order to pump effectively. Even though over 20% of 
OHCA patients show VF/VT as their initial rhythm, it is estimated that over 60% of these 
patients are refractory to current treatment and never achieve ROSC, or the patient dies before 
they reach the hospital.6 In an analysis of CPR duration, Grunau et al. showed that once CPR for 
patients with shockable rhythms reaches 48 minutes in duration, the probability of survival falls 
below 1%.17 In the same study, researchers found that for patients with non-shockable rhythms, 
that duration was 15 minutes.13,17 
Similarly, in an analysis of 654 adults who received standard CPR in the amiodarone arm 
of the ALPS trial (Amiodarone, Lidocaine, or Placebo Study) it was found that of the 34% 
(218/636) of ALPS patients who underwent CPR for over 40 minutes, none of them survived 
with neurologically favorable status (CPC 1 or 2).8,18 Data from the patients in the amiodarone 
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arm of the ALPS trial was extracted from this study, as amiodarone is part of the treatment 
protocol in compliance with the American Heart Association guidelines for ACLS. Both of these 
studies had large cohorts, with populations of over 600 subjects each. This helped to draw better 
conclusions with the data that was represented and show greater statistical analysis when 
comparing differences within the populations. Both studies showed a significant decrease in 
likelihood of neurologically favorable survival as CPR was prolonged. Although the ALPS trial 
did not provide analysis of non-shockable rhythms, the data for shockable rhythms was similar to 
that of Grunau et al. for the same population.17,18 These statistics show that with prolonged 
resuscitation of over 40 minutes, chances of survival with a CPC score of 1 or 2 are drastically 
low. When refractory VF/VT OHCA is established, if resuscitation efforts are to continue, it is 
essential to explore other means of management such as ECPR to increase odds of a favorable 
outcome.  
 
Extracorporeal Membrane Oxygenation (ECMO) 
 
ECMO is a form of cardiopulmonary life-support. During ECMO management, blood is 
drained from the venous system, then circulated outside the body through a membrane 
oxygenator, which acts as artificial lungs and oxygenates the blood while removing CO2. The 
blood then passes through a mechanical pump, which acts as an artificial heart, and reinfuses it 
into the body to perfuse all organs.19, 20 There are two forms of ECMO, including veno-venous 
(VV) ECMO and veno-arterial (VA) ECMO. This literature review will focus on VA-ECMO, as 
it has the ability to provide both cardiac and respiratory support, as opposed to VV-ECMO, 
which is used only to support respiratory dysfunction.   
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When VA-ECMO is used in the management of refractory VF/VT OHCA patients, blood 
is drained from the femoral vein and reinfused into the femoral artery via a percutaneously 
placed cannula. This cannulation technique serves as an advantage, as it is rapid and less 
invasive. This allows it the ability to be performed nearly everywhere, including the emergency 
room, cardiac catheterization lab, operating room, as well as in the field environment. Once 
ECMO is running and hemodynamic stability is established, the patient can be transferred with 
the entire unit.9 The goal of ECMO is to support the patient as a bridge to recovery, bridge to 
destination, or bridge to surgery by stabilizing systemic circulation until the heart can recover. 
Extracorporeal-CPR (ECPR), using ECMO for hemodynamic stability, has been shown to 
enhance survival for patients with refractory VF/VT OHCA, with survival rates as high as 40% 
to 50%.1,5,10,21-23 When a patient is in refractory VF/VT OHCA, time is of the essence. ECPR can 
provide an opportunity to stabilize these patients so that the cause of the cardiac arrest can be 
determined and reversed without neurologic deterioration.  
In a study at the University of Minnesota, an ECPR protocol was implemented in the 
management of refractory VF/VT OHCA (UMN-ECPR).5 Over the first 3 months of this 
protocol, 27 patients were transferred by EMS for OHCA, 18 of which met inclusion/exclusion 
criteria. Of these 18 patients, 9 (50%) of them survived with a neurologically favorable outcome 
(CPC 1 or 2). In a follow-up study, Bartos et al. looked at the outcome of 100 consecutive adult 
patients with refractory VF/VT OHCA that underwent the same ECPR protocol.1 Of the 100 
transported patients that met inclusion/exclusion criteria, 40 (40%) of them were discharged with 
a neurologically favorable outcome of CPC 1 or 2, as well as at a 3-month follow-up.1 This 
evidence suggests that patients in refractory VF/VT OHCA can benefit greatly from the ECPR 
protocol used in these studies. In the aforementioned CHEER trial, over a 32-month period, 26 
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patients (11 OHCA and 15 IHCA) with refractory cardiac arrest were treated with ECMO. Of 
these 26 patients, 14 (54%) of them survived to discharge with full neurological ability (CPC 
score 1). This group included 9/15 (60%) IHCA patients and 5/11 (45%) OHCA patients.14 
When comparing the UMN-ECPR protocol to conventional CPR of 170 patients meeting 
the same criteria and treated by the same EMS units, the ECPR protocol showed a much higher 
rate of favorable neurologic survival to discharge with CPC 1 or 2.5 As mentioned previously, in 
the patients treated with ECPR protocol, 9/18 (50%) survived with a favorable neurologic 
outcome, while only 14/170 (8.2%) patients treated with conventional CPR survived with a 
favorable neurologic outcome.21 In a study from Japan, neurologic outcomes of OHCA patients 
following management with either ECPR protocol or conventional CPR were compared.22 454 
patients met inclusion/exclusion criteria, including 260 patients in the ECPR group and 194 
patients in the non-ECPR group. Results of this study showed the ECPR management group to 
be superior for favorable outcomes (CPC 1 or 2) in comparison with the conventional CPR 
group. At the 1-month follow up, rate of favorable outcomes were 12.3% in the ECPR group and 
1.5% in the conventional CPR group. At 6-months, ECPR patients had a rate of 11.2% compared 
to 2.6% with the conventional CPR group. In another study, Wang et al. conducted a prospective 
observational study to compare the use of ECPR in patients with OHCA and patients with IHCA. 
Over 5 years, 31 patients were treated with the ECPR protocol for OHCA. In this OHCA group, 
the overall survival was 38.7%, with a favorable neurological outcome of 25.8%.23 These studies 
provided evidence that implementation of an ECPR protocol for the management of OHCA 
could serve to improve survival with a favorable neurologic outcome. 
 
ECPR Protocol Inclusion and Exclusion Criteria 
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Inclusion and exclusion criteria differed across all studies researched in this review. 
Though similar, each study had specifics that narrowed the patient population in which they treat 
with their prospective protocol. The UMN-ECPR study had the most extensive criteria of all the 
studies analyzed. Inclusion criteria included: 1) OHCA with presumed cardiac etiology cardiac 
arrest; 2) first presenting rhythm was shockable (VF or VT); 3) age 18 to 75 years; 4) received at 
least 3 direct current shocks without sustained ROSC; 5) received amiodarone 300mg; 6) body 
could accommodate a LUCAS automated CPR device and 7) transfer time from the scene to the 
cardiac catheterization lab (CCL) of less than 30 minutes. Exclusion criteria included: 1) ROSC 
before 3 shocks were delivered; 2) Nursing home residents; 3) Do Not Resuscitate (DNR)/Do 
Not Intubate (DNI) orders in place; 4) known terminal illness (eg, cancer, end‐stage liver, 
kidney, or heart disease); 5) traumatic arrest; 6) pulseless electrical activity and asystole; 7) 
significant bleeding and 8) manual CPR as the only option. In addition to this 
/  a, a  a   1    a  a  a   CCL 
arrival: 1) end- a  CO2 < 10 H ; 2) PaO2 < 50 H ; 3) a  a  >18 /L; a  4) 
  EMS a a   CCL a a  >90 . For patients that met inclusion/exclusion 
criteria, UMN-ECPR protocol called for the immediate transfer to the University of Minnesota 
while incorporating mechanical CPR with the LUCAS device en route. Upon arrival, patients 
were sent to the CCL where interventional cardiologists connected them to ECMO.5  
In the CHEER trial, the inclusion criteria included: 1) patients 18-65 years of age; 2) 
cardiac arrest due to suspected cardiac etiology; 3) chest compressions commenced within 10 
minutes by bystanders or EMS; 4) initial cardiac arrest rhythm of VF and 5) mechanical CPR 
device available. Patients were deemed as in refractory cardiac arrest after 30 minutes of CPR 
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with no ROSC.  If the above criteria were met, OHCA patients were transported to Alfred 
Hospital while receiving continuous mechanical CPR and infusion of 2 L of cold saline en route. 
Upon arrival to the emergency room, two critical care physicians connect the patient to ECMO. 
Once patient is hemodynamically stable, suspected cause of cardiac arrest is analyzed and treated 
and patient is sent to the intensive care unit (ICU).14  
The next study reviewed was a large prospective observational study from Japan that 
observed neurological outcomes of OHCA patients following management with either ECPR 
protocol or conventional CPR/non-ECPR protocol. Inclusion criteria included: 1) VF/VT on 
initial ECG; 2) cardiac arrest on hospital arrival with or without pre-hospital ROSC; 3) within 45 
minutes from onset of cardiac arrest to hospital arrival; 4) no ROSC within 15 minutes after 
hospital arrival and 5) age of 20-74 years. Exclusion criteria included: 1) poor activity of daily 
living prior to cardiac arrest; 2) non-cardiac origin; 3) core body temperature below 30°C and 4) 
if patient did not have informed consent from individuals representing them.22  
In the final study evaluated for this review, Wang et al. conducted a prospective 
observational study to compare the use of ECPR in patients with OHCA and patients with IHCA 
over a 5-year period. OHCA inclusion/exclusion criteria differed for IHCA and OHCA patients 
in this study. For OHCA patients, eligibility was considered if; 1) the arrest was witnessed; 2) 
conventional resuscitation was started within 6 minutes and 3) CPR was continued during 
transportation. Other exclusion criteria were: 1) OHCA of a traumatic origin; 2) preexisting 
multiple organ dysfunction; and 3) sustained ROSC for more than 20 min after OHCA.23  
When comparing the criteria in which these studies used to decipher between ECPR 
treatment vs. conventional CPR treatment, there were many similarities and differences across 
the studies evaluated. First, all but 1 of the studies mentioned the need for VF or VT to be the 
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initial heart rhythm. This is in line with what has been previously discussed in that VF and VT 
are shockable rhythms and carry a better prognostic factor than that of asystole and PEA, or non-
shockable rhythms. Next, all but 1 of the studies included the presumption of the cardiac arrest 
being of cardiac origin in their criteria. This factor holds importance because if it is of cardiac 
origin, this narrows the presumed treatments and PCI in the CCL will be more beneficial. 
Finally, all but the study from Japan mentioned the need for continuous CPR in their criteria. 
Continuous CPR serves an important role in the management of OHCA as this helps to 
consistently perfuse vital organs in the time that the heart has stopped pumping on its own. These 
3 studies also mentioned the importance of rapid CPR/ACLS upon onset of cardiac arrest. 
Without rapid response and continuous CPR, ischemic injury to these organs can cause serious 
dysfunction and eventually death.  
These studies also had many differences. The first way in which they differed was in the 
complexity of each  criteria. The UMN-ECPR criteria is longer than the others, especially 
that of Wang et al., each having 15 specific inclusion/exclusion criteria and 6 specific 
inclusion/exclusion criteria, respectively. Also, the CHEERS trial did not specify any exclusion 
criteria at all. Secondly, 2 of the studies mentioned specific time constraints in which the patient 
must be transferred to the hospital/CCL. The UMN-ECPR study inclusion criteria states that time 
of transport from the scene to CCL must be 30 minutes or less. This ensures that as long as the 
patient meets all inclusion criteria, they can be treated with PCI before extensive deterioration. 
The study from Japan requires the time from initial onset of cardiac arrest to the hospital be less 
than 45 minutes. This inclusion factor is in line with previously stated information that after 40-
45 minutes of conventional CPR, survival with a favorable neurologic outcome declines 
drastically.  Lastly, though similar, 3 out of the 4 studies mentioned had age ranges for patients 
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that could receive treatment included in their inclusion/exclusion criteria. This factor is 
significant in that these small differences in age brackets can decide whether or not ECPR 
protocol will be administered. When looking only at the age of a OHCA patient and not at any 
other prognostic markers, whether patients at the low and high ends of these ranges receive 
treatment is dependent on which protocol is being used.  
The breadth of these inclusion and exclusion criteria serve an important role in each 
 . C a  ba   a     b  a   survival with a 
favorable neurologic outcome in patients who receive the treatment. Without this criteria, time, 
money and resources could be used on patients whom are unlikely to survive with favorable 
neurologic outcomes. As always, it is up to EMS and providers to use clinical judgement to 
assess overall likelihood of a favorable outcome, as a single factor does not always carry the 
same weight from patient to patient. For example, a healthy 26-year-old with a lactic acid of 20 
mmol/L may have a better chance of a favorable outcome than an unhealthy 74-year-old with the 
same lactic acid level. This criteria must be assessed immediately upon arrival by EMS as shorter 
time from initial cardiac arrest to CCL/hospital is associated with more favorable outcomes. 
 
Discussion: 
The persistently high mortality rate associated with OHCA calls for a need for 
intervention. Conventional CPR, albeit very important to the overall outcome, does not always 
provide sufficient perfusion to vital organs in order to obtain a favorable neurological outcome, 
especially when it is prolonged in such cases as refractory VF/VT OHCA. The main purpose of 
this literature review was to analyze the impact of ECPR for the treatment of refractory VF/VT 
OHCA. Through the research analyzed in this review, it was found that there are many factors 
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that play a role in the successful outcome of these patients. This review focused on the 
components of CPR duration, ECPR protocol and survival with a favorable neurologic outcome. 
 
 CPR Duration: 
 
Through this literature review, it was concluded that as the duration of conventional CPR 
is prolonged, rate of survival with a favorable neurologic outcome declines.8, 15 In a randomized 
controlled trial, Reynolds et al. analyzed CPR duration in patients with EMS-treated OHCA. It 
was found that with conventional CPR, 90% of subjects with a favorable neurologic outcome 
obtain ROSC within 20 minutes, and 99% obtain ROSC within 37 minutes. With these numbers, 
it is unclear as to when resuscitation efforts should be continued or be terminated. Prolonged 
conventional CPR can also have detrimental metabolic effects on the body.8 In a similar study 
mentioned previously, Grunau et al. compared OHCA patients with initially shockable rhythms 
to OHCA patients with non-shockable rhythms. In terms of survival with a favorable neurologic 
outcome, the findings in this study heavily favored patients with initially shockable rhythms. 
Another factor in this study that increased odds of survival with a favorable neurologic outcome 
was age. When younger patients went into cardiac arrest, it was found that a higher percentage 
were able to survive with favorable neurologic outcomes as conventional CPR was prolonged.  
Another study compared the rate of survival in relation to the duration of CPR in 2 
groups of patients with refractory VF/VT OHCA. 1 group was treated with an ECPR protocol 
and the other group was treated with conventional CPR. The ECPR group showed significantly 
greater rates of survival with a favorable neurologic outcome in all cases in which CPR lasted 
longer than 20 minutes. Similar to the previously mentioned studies, of the 218 patients in the 
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conventional CPR group that received CPR for over 40 minutes, none survived with a favorable 
neurologic outcome (CPC 1 or 2). In comparison, of the 36 patients in the ECPR group that 
received conventional CPR for 50-59 minutes followed by ECMO, 9 of them (25%) survived 
with a favorable neurologic outcome and 19% of patients survived with a favorable neurologic 
outcome even after 60 minutes or greater of conventional CPR followed by ECMO.8 Most likely, 
there are factors that differentiate patients chosen for ECPR and those not. However, there were 
no survivors in the group who received conventional CPR which makes it difficult to argue that 
this is an effective strategy once the duration of conventional CPR reaches 40 minutes. This 
study shows that even after prolonged resuscitation attempts occur, at durations when 
conventional CPR fails to keep the patient alive, ECPR protocol still shows benefit in survival 
with a favorable neurologic outcome. 
Although these studies focused on the duration of conventional CPR, there were several 
other factors that will affect the survival with favorable neurologic outcomes in patients treated 
with ECPR. Some of these factors include; no-flow time, causes of arrest, refractory arrest or re-
arrest, and post-resuscitation care.24 While conventional CPR still holds true as an essential part 
of the initial management of OHCA, the duration at which it can adequately sustain life is 
undetermined. Although these studies do not necessarily construct a maximum time limit at 
which conventional CPR should be terminated, they can help to guide conventional CPR in 
terms of minimum duration. When evaluating these numbers in terms of conventional CPR 
duration and the likelihood of survival with a favorable neurologic outcome, these studies 
suggest the need for additional intervention at a certain duration to increase the chances of 
survival with CPC 1 or 2. ECPR is associated with improved survival with a favorable 
neurologic outcome for patients with shockable OHCA compared with conventional CPR at all 
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durations of time less than 60 minutes. Also, it may allow successful treatment of patients 
receiving prolonged conventional CPR up to 60 to 98 minutes, but not without the risk of 
survival with an unfavorable neurologic outcome.8 Termination of conventional CPR without 
additional treatment leads to subsequent death in cardiac arrest patients. This termination of 
resuscitative attempt is predicated by EMS members when they feel these attempts become 
futile. If additional intervention is available, this termination of resuscitative efforts may be 
delayed, and inevitable death will be avoided for the time being with possible ROSC due to 
continued resuscitative efforts, or with ECPR. 
 
ECPR Protocol: 
  
When a patient suffering from VF/VT OHCA is deemed refractory to conventional 
ACLS management, there are three options; continue current management indefinitely until 
ROSC is achieved, call for termination of resuscitation and subsequent death, or transport to 
ECMO enabled medical facility for life saving measures. In multiple studies, ECPR protocol 
using ECMO for hemodynamic stability has recently been shown to enhance survival with a 
favorable neurologic outcome for patients with refractory VF/VT OHCA.1,14,16,21,22 In these 
patients, the ECPR protocol ab   a    a  a a  . ECPR 
provides hemodynamic support, which in turn, stops the progression of ischemic injury prior to 
ROSC, allows time to regulate metabolic instability, and provides time to treat the underlying 
cause of the refractory cardiac arrest.8 For each patient that is considered for ECPR, there are 
specifications that must be met in order to receive the treatment. The inclusion and exclusion 
criteria discussed previously is the basis of which patients are treated with ECPR protocol and 
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which ones are not. ECPR protocols differed slightly across studies, but maintained many 
similarities to draw conclusions from. Overall, the main factors included within each article to 
best predict likelihood of survival with a favorable neurologic outcome after prolonged 
resuscitations were; 1) initial shockable cardiac rhythm; 2) bystander CPR; 3) witnessed cardiac 
arrest and 4) OHCA being of cardiac origin.1,5,14,22 Meeting inclusion and exclusion criteria plus 
these key features warrant early consideration of novel therapies such as ECPR.  
Through all the research evaluated for this literature review, early recognition and 
subsequent bystander or professional conventional CPR initiation was the most important factor 
in successful outcomes. There are some elements of OHCA that can be overcome by ACLS and 
ECPR, but cerebral hypoxia/anoxia carries a severely high mortality rate and is the main cause 
for death in these patients.11 Not only is early recognition of cardiac arrest important, but early 
recognition by EMS of cardiac arrest which is refractory to conventional treatment carries 
extremely high importance in the ECPR protocol. Like conventional CPR, time is of the essence 
with ECPR as well. If these patients are not transported and started on ECMO in a timely 
manner, CCL activation and treatment may not be enough to offer benefit.21 The time in which 
conventional CPR should be stopped and ECPR protocol initiated is somewhat unclear. Studies 
outlined in this review show that prolonged conventional CPR is associated with a poorer 
outcome, so it would be advantageous to initiate ECPR at an earlier time. Kim et al., proposed 
that the ideal cut-off time to sw   a  CPR  a  ECPR  21 .24 
This allows enough time for the patient to be transported and cannulated in a shorter amount of 
time from the onset of cardiac arrest. This stresses the importance to have clear guidelines in 
place along all levels of ECPR protocol from local EMS all the way to interventional 
cardiologists as ECPR requires a well-organized, succinct team effort. 
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Throughout this review, many benefits of ECPR have been discussed. These benefits, 
however, must be considered along with the significant risks in the decision to institute ECPR on 
refractory OHCA patients. Bleeding is the most frequent and most serious complication 
associated with ECPR support.25 The cannulation technique used in most cases for VA-ECMO is 
through the femoral artery and vein. This procedure, if not done correctly, can have detrimental 
effects on the outcome of these patients. Studies in this review differed in who performed the 
cannulation. In the UMN-ECPR protocol, Yannopoulos et al. reported cannulation of femoral 
artery and vein was performed with percutaneous technique and ultrasound guidance. This study 
emphasized the importance of this procedure and the need for interventional cardiologists to 
perform it.5 In the CHEER-ECPR protocol, upon arrival to the emergency room, mechanical 
CPR is paused, and two critical care physicians connect the patient to ECMO using percutaneous 
cannulation of the femoral vessels.14 The UMN-ECPR protocol reported 2 complications in 
which patients had moderate bleeding around the cannulation site, this was controlled with the 
decrease in anticoagulation therapy. The CHEER-ECPR protocol reported the need for blood 
transfusion in 16 of the 26 patients treated with ECMO. They also reported that 2 patients died 
primarily of major bleeding complications. These 2 studies show drastic differences in both the 
rate and severity of bleeding complications and it highlights the importance of who is performing 
the cannulation procedure. Depending on the level of training the critical care physicians from 
the CHEER-ECPR protocol had in this process, one could theorize the importance of advanced 
training. Interventional cardiologists have specialized training in techniques such as this, which 
may help to limit complications. 
 
Neurologic Outcomes: 
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Six studies examined the outcome of patients that were treated with ECPR in the event of 
VF/VT refractory cardiac arrest. 1,14,16,21-23 The primary outcome of these studies was defined as 
neurologically favorable survival (CPC 1 or 2). In each of these studies, VF/VT refractory 
OHCA patients treated with ECPR protocol showed superior outcomes when compared to the 
same population of patients treated with conventional CPR alone. Each study mentioned factors 
that were associated with survival with a favorable neurologic outcome. First, rapid EMS 
response time and shorter time from 911 call to CCL. As discussed previously, prolonged CPR is 
associated with higher mortality. It was concluded that faster initiation of ECPR lead to better 
outcomes. Secondly, cardiac arrest in a public place followed by rapid bystander CPR is essential 
to the overall success of ECPR. Although it was not shown to not be as proficient as ECPR, early 
bystander conventional CPR plays a critical role to initiate the reperfusion process after the onset 
of cardiac arrest. Limiting the time in which there is no blood flow may be the biggest factor in 
association with decreasing likelihood of ischemic brain injury. Lastly, evidence of reversible 
coronary artery disease can improve outcomes because it allows for providers the chance to use 
PCI to resolve the defect that is causing the cardiac arrest.26 
 Many of the studies analyzed in this review focused on the survival with a favorable 
neurologic outcome. The other side of this spectrum of outcomes would be death, as well as 
survival with an unfavorable neurologic outcome (CPC 3 or greater). Obviously, when given the 
choice of survival with a favorable neurologic outcome and death, the former is the easy choice 
in most cases. When favorable neurologic status is not definite, this can become a question of 
ethical debate. As mentioned previously, a CPC score of 3 or greater indicates severe cerebral 
disability with limited cognition and the dependence of others for activities of daily living.12 
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When a patient suffering from OHCA does not have any of the factors listed in the previous 
paragraph and the duration of conventional CPR is drawn out, there is an increase in the chance 
for survival with an unfavorable outcome. Bartos et al. reported the risk of survival with a CPC 
score of 3 or greater increased to 9% (3 of 35) at 60 to 69 minutes of conventional CPR.8 While it 
is easy to look at some of these statistics and see any increase in likelihood of survival as an 
encouraging marker, it is important to evaluate the quality of life and the chance this patient may 
not recover from this unscathed. These are the risks that must be weighed when considering a 
patient for ECPR management in the setting of OHCA after prolonged resuscitation efforts have 
not served beneficial. 
 
Limitations 
 
 There were limitations found within each article. First, the sample size was extremely 
small for several studies which examined the use of ECPR protocol in the treatment of refractory 
VF/VT OHCA. Many studies had 100 or less patients, which makes it difficult to form overall 
conclusions that can be applied to large populations. In addition to small sample sizes, quality of 
treatment among facilities could vary. Some of the observational studies assessed multiple 
hospitals and medical facilities. This variability in treatment protocols and management 
strategies could alter outcomes within different populations. Also, many of these protocols had 
criteria that narrowed the patient population that was treated. VF and VT are both shockable 
rhythms and have greater implications for survival than asystole and pulseless electrical activity 
(PEA), which are considered non-shockable rhythms. By excluding patients with non-shockable 
rhythms from the treatment cohort, numbers could be skewed to show improved survival rate as 
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patients in VF/VT already have a higher chance of survival. In contrast, if all asystole and PEA 
patients are placed into the compared cohort, their decreased chance of survival will negatively 
skew mortality rate. Finally, the ethical dilemma to perform randomized control trials on 
refractory VF/VT OHCA patients causes difficulty in drawing conclusions. These critically ill 
patients need effective treatment for survival and it would be unethical to not provide life-saving 
treatment if it is available. 
 
Conclusion: 
While conventional CPR remains essential in the management of OHCA, ECPR using 
ECMO has proven to be effective in improving survival with favorable neurologic outcomes in 
patients suffering from refractory VF/VT OHCA. ECPR is able to provide hemodynamic support 
to patients that cannot provide it for themselves and gives medical providers the ability to 
diagnose the underlying cause of the cardiac arrest, all while maintaining perfusion and 
sustaining neurologic function. The persistently high mortality rate in this patient population 
calls for an intervention and several studies have shown the survival benefit that ECPR provides. 
These studies concluded that major factors that improve outcomes are timely recognition and 
prompt EMS response, rapid bystander CPR, evidence of reversible coronary artery disease and 
shorter duration of time from initial arrest to the CCL. The longer a patient is without cardiac 
function, the greater chance of mortality and unfavorable neurologic outcomes (CPC 3 or 
greater). If the heart is unable to pump blood throughout the body and CPR is inefficient in doing 
so, ECPR is the next best step in providing life-saving management. 
Each step in this process weighs heavily on a system-based protocol in which an entire team 
must be involved for a successful outcome. In the studies evaluated in this review, a specific 
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system was in place to expedite the entire process. This efficiency can be the difference between 
life and death for some patients. There exists a need for these protocols to be implemented into a 
greater number of medical systems. This would allow for exposure to a larger patient population 
and in turn, decreased mortality rates. Although there is a brevity of research on exact 
implementation of specific protocol, the current studies show encouraging numbers. With 
continued research on this topic, exact protocols can be assessed and reconfigured to best serve 
the patient including personnel, equipment, logistics and collaboration with EMS.  
In a proposed randomized control study from 2012, Belohlavek et al. randomized patients 
into a control arm in which standard care was used to treat OHCA without ROSC and to a 
a  a     a  a  a    a al chest 
compression and transported to a medical center for the initiation of ECPR.11 This study is still 
ongoing without current results, but it does propose a different approach to studies around 
OHCA. This study will help to answer some of the questions and decrease some of the 
limitations involved with other observational studies. Since ECPR is not the first line treatment 
for refractory OHCA and there are no guidelines stating the need for ECPR in the treatment of 
all OHCA, standard care with conventional CPR and ACLS measures still offer life-saving 
treatment. This study will also help to answer questions on the implications of ECPR and how it 
can be definitively used over a wider patient population in the management of refractory OHCA. 
The randomization process serves as a control to limit bias and it provides a way in which cause-
effect relationships can be determined.  
All protocols researched in this review have shown improved neurologic outcomes when 
compared to conventional CPR alone. Randomized control trials are difficult in this critical 
condition, as not providing life-saving therapy when it is available would be unethical. ECPR 
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offers therapy in the management of refractory cardiac arrest with numerous studies now 
showing a survival benefit.  Providing patients with access to ECPR in a timely manner involves 
a community-wide approach in both the in-hospital and out-of-hospital setting. Continued 
research is needed to increase the number of patients treated and in turn, provide better 
clarification to protocol and specific practices that can continue to decrease the mortality rate and 
improve neurologic outcomes in a condition that has had a high mortality rate for too long. 
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